Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial by Ruben A. Mesa, Richard T. Silver, Srdan Verstovsek, John Mascarenhas, Craig M. Kessler, Damiano Rondelli, Judy D. Goldberg, Roberto Marchioli, Erin P. Demakos, Lewis R. Silverman, Ronald Hoffman

Get full text